Skip to main content
芭薇股份 logo

芭薇股份 — Investor Relations & Filings

Ticker · 920123 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 240 across all filing types
Latest filing 2025-08-21 Declaration of Voting R…
Country CN China
Listing Beijing Stock Exchange 920123

About 芭薇股份

https://www.gzbawei.com/

Guangdong Bawei Biotechnology Corp., Ltd. is a comprehensive beauty and personal care solution provider specializing in research, development, production, and testing. The company offers integrated OEM, ODM, and OBM services, covering a wide range of product categories including skincare, hair care, body care, and makeup. Bawei is recognized for its commitment to scientific innovation, operating advanced R&D laboratories and an independent third-party testing center that ensures product safety and efficacy. By leveraging automated production lines and a rigorous quality management system, the company serves a diverse portfolio of domestic and international brands. Its core focus remains on delivering high-quality, customized formulations and manufacturing excellence to meet evolving consumer demands in the global beauty market.

Recent filings

Filing Released Lang Actions
湖南启元律师事务所关于广东芭薇生物科技股份有限公司2025第一次临时股东会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 80% confidence The document is a legal opinion letter (“法律意见书”) from an external law firm certifying the convening, attendance, voting procedures, and vote results of the company’s 2025 first extraordinary general shareholders’ meeting. Although it is issued by counsel, its primary content is the official voting results and validation of those results, which corresponds to the Declaration of Voting Results & Voting Rights Announcements (DVA) category.
2025-08-21 Chinese
独立董事辞职公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of an independent director from the company's board. It details the resignation date, reasons, impact on the board composition, and legal compliance. There is no financial data, no report attached or referenced as being published, and no mention of financial results or other report types. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2025-08-06 Chinese
独立董事任命公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of an independent director and adjustments to the audit committee of the company's board. It details the nomination, qualifications, and approval process for the new independent director. There is no financial data, earnings information, or report publication mentioned. The content focuses on changes in the company's board of directors and senior management. Therefore, this fits the category of Board/Management Information (MANG). The document length is short and it is not a report or announcement of a report publication, so it is not RPA or RNS.
2025-08-06 Chinese
独立董事候选人声明与承诺（李学楠）
Board/Management Information Classification · 95% confidence The document is a statement and commitment by an independent director candidate, detailing qualifications, compliance with laws and regulations, and declarations of independence. It is a formal announcement related to board member candidacy rather than a financial report, audit, or management discussion. There is no financial data, earnings information, or report publication. The content fits the category of Board/Management Information (MANG), as it concerns the nomination and declaration of a board member candidate.
2025-08-06 Chinese
关于召开2025年第一次临时股东会通知公告（提供网络投票）
AGM Information Classification · 95% confidence The document is a notice announcing the convening of the 2025 first extraordinary general meeting of shareholders (临时股东会通知公告) for Guangdong Bawei Biotechnology Co., Ltd. It details the meeting date, voting methods (including online voting), agenda items, registration procedures, and other logistical information. The document does not contain financial statements, audit results, or detailed financial performance data. It is not a report but an announcement about a shareholder meeting. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or similar shareholder meetings. The document length is 2638 characters, which is consistent with a meeting notice rather than a full report.
2025-08-06 Chinese
第四届董事会第六次会议决议公告
Board/Management Information Classification · 100% confidence The document is a formal announcement of resolutions passed at the sixth meeting of the fourth board of directors of Guangdong Bawei Biotechnology Co., Ltd. It details the meeting's convening, attendance, and the approval of specific board proposals, including the election of an independent director and the proposal to convene an extraordinary shareholders' meeting. The document does not contain financial statements or detailed financial analysis, nor does it present audit results or earnings data. It is clearly a board meeting resolution announcement, which fits the category of Board/Management Information (MANG). The document length is short (1161 characters), and it is not an announcement of a report publication but a substantive announcement of board decisions.
2025-08-06 Chinese

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.